1. Home
  2. VINP vs CTKB Comparison

VINP vs CTKB Comparison

Compare VINP & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vinci Partners Investments Ltd.

VINP

Vinci Partners Investments Ltd.

HOLD

Current Price

$10.84

Market Cap

753.0M

Sector

Finance

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.48

Market Cap

595.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VINP
CTKB
Founded
2009
1990
Country
Brazil
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
753.0M
595.2M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
VINP
CTKB
Price
$10.84
$4.48
Analyst Decision
Strong Buy
Hold
Analyst Count
2
4
Target Price
$14.00
$5.63
AVG Volume (30 Days)
75.5K
482.7K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
5.72%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$193,015,000.00
Revenue This Year
$18.07
$5.42
Revenue Next Year
$12.74
$7.03
P/E Ratio
$24.41
N/A
Revenue Growth
N/A
17.67
52 Week Low
$9.20
$2.37
52 Week High
$13.61
$6.18

Technical Indicators

Market Signals
Indicator
VINP
CTKB
Relative Strength Index (RSI) 49.54 47.26
Support Level $10.56 $4.07
Resistance Level $13.43 $4.51
Average True Range (ATR) 0.46 0.18
MACD 0.01 -0.02
Stochastic Oscillator 41.80 53.91

Price Performance

Historical Comparison
VINP
CTKB

About VINP Vinci Partners Investments Ltd.

Vinci Compass Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Share on Social Networks: